Trial Profile

Prospective Study on DEXTENZA Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 05 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary) ; Ofloxacin; Prednisolone acetate
Indications Ocular inflammation; Ocular pain; Postoperative pain
Focus Adverse reactions; Therapeutic Use
Acronyms SUSTAIN

Most Recent Events

07 Jan 2024 Status changed to discontinued due to COVID-19 challenges to recruitment.
26 Jul 2023 Status changed from recruiting to completed.
21 Mar 2023 Planned End Date changed from 30 Apr 2023 to 31 Dec 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com